Biological Skin Substitutes to dominate in the Global Skin Substitutes Market through 2028
Global Skin Substitutes Market is expected to be driven by the increasing prevalence
of severe skin injuries in the forecast period.
According to TechSci Research report, “Skin Substitutes Market –Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, Global
Skin Substitutes Market is anticipated to grow at an impressive rate in the
forecast period, 2024-2028. This can be attributed to the increasing
number of developments happening in the global skin substitutes market such as the
use of advanced materials, such as nanofibers and hydrogels, and the
development of new manufacturing techniques that allow for the creation of
products that are more consistent and reliable. These advances are likely to
lead to the creation of products that are more effective in treating a wider
range of skin injuries.
Besides,
growing popularity of xenotransplantation is expected to create lucrative
opportunities for the growth of global skin substitutes market, especially the
biological substitutes, xenograft segment. However, lack of awareness
pertaining to skin substitutes especially in the emerging countries can slow
down the global skin substitutes market growth. Also, lack of skilled
professionals who can use and perform procedures using skin substitutes can
further restrict the growth of global skin substitutes market.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Skin Substitutes Market”
Global Skin
Substitutes Market can be segmented by type, by application, by end user, and
by region. Based on type, global skin substitutes market can be divided into
biological and synthetic. Biological skin substitute can be further categorized
into autografts, allografts, and xenografts. Biological skin substitute market
dominated the market in 2022 on account of their high success rate and low risk
of rejection by the patient's body. However, synthetic skin substitutes are
also expected to see significant growth in the coming years due to
technological advancements in the field.
Autografts are
skin substitutes that are taken from a patient's own body and transplanted onto
the affected area. They are often used in cases where a patient has a small
wound or injury, and there is enough healthy skin available to cover the
affected area. Autografts have a very high success rate, as the body is less
likely to reject the transplanted tissue. Allografts are skin substitutes that
are taken from a donor, usually a cadaver. These substitutes are commonly used
in the treatment of large burn injuries, as they can cover a larger area than
autografts. However, there is a higher risk of rejection with allografts, as
the tissue is not from the patient's own body. Xenografts are skin substitutes
that are taken from a different species, usually a pig. These substitutes are
often used in the treatment of large burn injuries or in cases where a patient
has a weakened immune system. However, the risk of rejection with xenografts is
very high, as the tissue is not from a human.
Regionally, the
Asia Pacific region is expected to see significant growth in the coming years in
the global skin substitute market due to increasing investment in healthcare
infrastructure and rising awareness of advanced wound care products.
Major companies operating in the Global Skin
Substitutes Market are:
- Amarantus
BioScience Holdings, Inc.
- Organogenesis,
Inc
- Acelity L.P.,
Inc.
- Smith &
Nephew plc
- BSN Medical
GmbH
- Molnlycke
Health Care AB
- Integra
LifeSciences Corporation
- Medtronic Plc
- Tissue Regenix
Ltd.
- Stratatech
Corporation
These
companies are investing in research and development to develop new and
innovative products to meet the growing demand for advanced wound care
products. One recent product launch in the field of skin substitutes is
Apligraf, a product developed by Organogenesis. Apligraf is a bilayered skin
substitute that contains both living cells and a matrix of proteins that mimic
the structure of the skin. This product is designed to treat chronic wounds, such
as diabetic foot ulcers and venous leg ulcers, and has been shown to be highly
effective in promoting healing and reducing the risk of infection. Apligraf was
first approved by the FDA in 1998, and has since been used to treat millions of
patients around the world.
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“The global
skin substitutes market has seen a number of exciting new product launches in
recent years, as companies develop new and innovative products designed to
improve the treatment of a range of skin injuries. These products are aimed at
creating new solutions that are more effective, more versatile, and easier to
use, and are likely to have a major impact on the future of the field. As the
demand for effective skin substitutes continues to grow, it is clear that
companies will continue to innovate and develop new products that can help
improve patient outcomes and reduce the risk of complications, thereby creating
prospects for the growth of global skin substitutes market.” said Mr. Karan
Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
Skin Substitutes Market - Global Industry Size,
Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Type
(Biological v/s Synthetic), By Application (Acute Wounds v/s Chronic Wounds),
By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others), By
Region and Competition”, has
evaluated the future growth potential of Global Skin Substitutes Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Skin Substitutes Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com